首页>
外国专利>
use of ranolazine in combination with at least one remodeling agent for reversal of left ventricular remodeling in the treatment of heart failure.
use of ranolazine in combination with at least one remodeling agent for reversal of left ventricular remodeling in the treatment of heart failure.
展开▼
机译:雷诺嗪与至少一种改型剂联合用于逆转左心室改型在心力衰竭中的应用。
展开▼
页面导航
摘要
著录项
相似文献
摘要
USE OF RANOLAZINE IN COMBINATION WITH AT LEAST ONE REMODELING AGENT FOR REVERSAL OF VENTRICULAR REMODELING LEFT IN HEART FAILURE TREATMENT. The present invention relates to a method of reversing left ventricular remodeling by combined administration of therapeutically effective amounts of ranolazine and at least one remodeling agent, which may be an ACE inhibitor, an ARB or a beta blocker. The method finds utility in treating heart failure. The present invention also relates to pharmaceutical formulations which are suitable for such combined administration.
展开▼